NASDAQ:PXMD

Paxmedica Stock Insider Trading

Healthcare > Biotechnology

Buy PXMD

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Nov 17, 2025

PaxMedica Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -100.00. In total, the insiders bought 200K and sold 476.62K PXMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-100.00
● Buy	200K shares
● Sell	476.62K shares
4% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 12, 2024 Sell	Common Stock F-InKind	Weisman Howard J. Chief Executive Officer	CEO / President	2 927 Value: $2K
Mar 12, 2024 Sell	Common Stock F-InKind	Sheldon Stephen CFO And COO	C-Suite Officer	3 356 Value: $2K
Mar 12, 2024 Sell	Common Stock F-InKind	Rome Zachary Director	Director	4 904 Value: $3K
Mar 12, 2024 Sell	Common Stock F-InKind	Larochelle Karen Director	Director	604 Value: $417
Mar 12, 2024 Sell	Common Stock F-InKind	Hough David W. Chief Medical Officer	Officer	1 452 Value: $1K
Mar 12, 2024 Sell	Common Stock F-InKind	Coelho John F Director	Director	207 Value: $143
Mar 12, 2024 Sell	Common Stock F-InKind	Casamento Charles J Director	Director	992 Value: $684
Mar 12, 2024 Sell	Common Stock F-InKind	Casamento Charles J Director	Director	992 Value: $684
Mar 12, 2024 Sell	Common Stock F-InKind	Coelho John F Director	Director	207 Value: $143
Mar 12, 2024 Sell	Common Stock F-InKind	Hough David W. Chief Medical Officer	Officer	1 452 Value: $1K
Mar 12, 2024 Sell	Common Stock F-InKind	Larochelle Karen Director	Director	604 Value: $417
Mar 12, 2024 Sell	Common Stock F-InKind	Rome Zachary Director	Director	4 904 Value: $3K
Mar 12, 2024 Sell	Common Stock F-InKind	Sheldon Stephen CFO And COO	C-Suite Officer	3 356 Value: $2K
Mar 12, 2024 Sell	Common Stock F-InKind	Weisman Howard J. Chief Executive Officer	CEO / President	2 927 Value: $2K
Feb 21, 2024 Sell	Common Stock F-InKind	Sheldon Stephen CFO And COO	C-Suite Officer	243 Value: $160
Feb 21, 2024 Sell	Common Stock F-InKind	Hough David W. Chief Medical Officer	Officer	291 Value: $192
Feb 21, 2024 Sell	Common Stock F-InKind	Hough David W. Chief Medical Officer	Officer	291 Value: $192
Feb 21, 2024 Sell	Common Stock F-InKind	Sheldon Stephen CFO And COO	C-Suite Officer	243 Value: $160
Jan 29, 2024 Sell	Common Stock S-Sale	Larochelle Karen Director	Director	78 Value: $37
Jan 29, 2024 Sell	Common Stock S-Sale	Weisman Howard J. Chief Executive Officer	CEO / President	372 Value: $175
Jan 29, 2024 Sell	Common Stock F-InKind	Casamento Charles J Director	Director	97 Value: $74
Jan 29, 2024 Sell	Common Stock S-Sale	Coelho John F Director	Director	27 Value: $13
Jan 29, 2024 Sell	Common Stock S-Sale	Rome Zachary Director	Director	811 Value: $389
Jan 29, 2024 Sell	Common Stock S-Sale	Rome Zachary Director	Director	811 Value: $389
Jan 29, 2024 Sell	Common Stock S-Sale	Larochelle Karen Director	Director	78 Value: $37

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks